Merck Sharp & Dohme’s
MDS is a research-intensive biopharmaceutical company that develops important medicines and vaccines.
Singapore OKs molnupiravir for COVID-19 treatment
Singapore OKs molnupiravir for COVID-19 treatment
The drug is the second oral antiviral medicine authorised for COVID-19 treatment.
Most Read
1. HMI Medical targets more overseas patients with robotic surgery push 2. Blood glucose monitoring system market to hit $25.4b by 2030 3. Australian gov’t allocates $970,000 to sustain cohealth GP services 4. New Zealand unveils 10-year Health Digital Investment Plan 5. Precious Medical Group launches $121.m cancer centre and hospital in JohorResource Center
Read Here
Advertise
Sign Up
Awards
Mar
26
Events
Event News
Healthcare Asia Awards 2025 Winner: Lee Ligang Zhang of iKang Healthcare Group
Lee Ligang Zhang of iKang Healthcare Group highlights how AI and precision diagnosis are transforming healthcare delivery today.
